Modification of metabolic syndrome parameters following the administration of polyglucosamine L112: results of a subgroup analysis of subjects enrolled in a double blind randomised placebo controlled clinical investigation

Abstract Background Up to now, scientific literature has not reported studies evaluating the efficacy of polyglucosamine L112 on body weight, insulin resistance, and cholesterol levels in patients with metabolic syndrome, despite its known antioxidant properties and potential to reduce these paramet...

詳細記述

書誌詳細

主要な著者:	Mariangela Rondanelli, Simone Perna, Matteo Della Porta, Federico Lombardoni, Zaira Patelli, Mara Nichetti, Clara Gasparri, Elvira Pistolesi, Benvenuto Cestaro, Roberta Cazzola
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2025-09-01
シリーズ:	BMC Nutrition
主題:	Polyglucosamine L112 Metabolic syndrome Insulin resistance Visceral adipose tissue Fat mass Fat-soluble vitamins
オンライン･アクセス:	https://doi.org/10.1186/s40795-025-01153-8
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!